Daniel Graifman, MBA


Daniel Graifman is Founder and President of Thylacine Bio. He has extensive experience in investment analysis and operations in early stage technology companies. Prior to Thylacine Bio, he served as a consultant for the Harvard Life Lab, working with diagnostic startups on pharmaceutical partnerships and competitive positioning.

Daniel previously led strategic partnerships for Swift Navigation, a deep tech autonomous vehicle firm, and launched markets for DoorDash, a consumer logistics service.

Daniel has an MBA from Harvard Business School where he was a Rock Venture Partner, and received a B.A. from Stanford University where he was a Mayfield Fellow.

More team members

Andrew Fradkin, JD
General Counsel
Walter Greenblatt, MBA
Chief Financial Officer
Mike McGinnis, MS, MBA
Head of Government Relations
Anne Moscona, MD
Ruth Karron, MD
Matteo Porotto, PhD
Elma Hawkins, PhD, MBA
Chairwoman of the Board
Fred Hayden, MD
Joan Fusco, PhD
Chief Development Officer
Tom Monath, MD
Chief Medical Officer
Sean Whelan, PhD
Allen Duplantier, PhD
Principal investigator